Fusobacterium nucleatum in cancer: from bystander to driver
Open Access
Abstract
The human microbiota comprises a diverse and extensive community of microorganisms that participate in intricate interactions with the host, several of which are increasingly acknowledged as key modulators of health and disease. Among these, Fusobacterium nucleatum ( Fn ), an oral commensal bacterium, has emerged as a significant oncobacterium implicated in tumour progression. The Fn genus comprises distinct subspecies, clades and strains, exhibiting marked phylogenetic and physiological heterogeneity. Consequently, pinpointing the true functional modulators within this complex community and elucidating their mechanisms in various physio-pathological states remains a critical yet challenging endeavour. Moreover, the complete mechanism underlying Fn ’s function across different spatial locations and physiological states remains to be fully elucidated. This review details the genetic and phenotypic heterogeneity among Fn subspecies, which underlies their differential characteristics and niche adaptation. We further delineate key effectors of Fn , such as adhesins, metabolites and exoproteins, which collectively facilitate host cell invasion, immune evasion and chemoresistance induction. We explore the translational potential of Fn , underscoring its utility as a diagnostic biomarker and a promising target for novel therapeutic strategies.Keywords
Funding Information
- Cancer Innovative Research Program of Sun Yatsen University Cancer Center (CIRP-SYSUCC-0005)
- National Natural Science Foundation of China (82372592)
- National Natural Science Foundation of China (82461160321)
- Young Talents Program of Sun Yat-sen University Cancer Center (YTP-SYSUCC-0010)
This publication has 189 references indexed in Scilit:
- Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potentialAlzheimer's & Dementia, 2025
- Neutrophil‐Mimicking Nanomedicine Eliminates Tumor Intracellular Bacteria and Enhances Chemotherapy on Liver Metastasis of Colorectal CancerAdvanced Science, 2025
- Tailoring a Functional Synthetic Microbial Community Alleviates Fusobacterium nucleatum‐infected Colorectal Cancer via Ecological ControlAdvanced Science, 2025
- Integrated spatial multi‐omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progressionClinical and Translational Medicine, 2025
- Emerging strategies for combating Fusobacterium nucleatum in colorectal cancer treatment: Systematic review, improvements and future challengesExploration, 2023
- Antibacterial Fusobacterium nucleatum‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal CancerAdvanced Materials, 2023
- Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neckCancer, 2022
- Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor TissueJAMA Oncology, 2017
- Fusobacterium nucleatumand T Cells in Colorectal CarcinomaJAMA Oncology, 2015
- Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the hostInflammatory Bowel Diseases, 2011